Naunton Mark, Al Hadithy Asmar F Y, Brouwers Jacobus R B J, Archer David F
Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands.
Menopause. 2006 May-Jun;13(3):517-27. doi: 10.1097/01.gme.0000191881.52175.8c.
To review the pharmacology, pharmacokinetics, safety, and efficacy of a gel containing estradiol that is applied to the skin.
MEDLINE and EMBASE searches were conducted from 1966 to March 2005. Additional references were identified from bibliographies from selected studies in addition to approved product information.
Estradiol gel is indicated for the relief of moderate to severe vasomotor symptoms in menopausal women, and moderate to severe symptoms of vulvar and vaginal atrophy. Women who are intolerant of the oral route, have had previous hypersensitivity skin reactions, or have had difficulties with adhesive patches are ideal candidates for estradiol gel.
Estradiol gel can effectively reduce menopause symptoms with minimal side effects. Long-term safety data of estradiol gel are required.
综述一种经皮应用的含雌二醇凝胶的药理学、药代动力学、安全性及疗效。
检索1966年至2005年3月期间的MEDLINE和EMBASE数据库。除了已批准的产品信息外,还从所选研究的参考文献中识别出其他参考文献。
雌二醇凝胶适用于缓解绝经后女性的中度至重度血管舒缩症状,以及中度至重度外阴和阴道萎缩症状。不耐受口服途径、既往有皮肤过敏反应或使用贴片有困难的女性是雌二醇凝胶的理想适用人群。
雌二醇凝胶能有效减轻绝经症状,副作用最小。需要雌二醇凝胶的长期安全性数据。